<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-03178R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0002086</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Physiology/Muscle and Connective Tissue</subject></subj-group></article-categories><title-group><article-title>Fiber Type-Specific Nitric Oxide Protects Oxidative Myofibers against Cachectic Stimuli</article-title><alt-title alt-title-type="running-head">Skeletal Muscle Wasting</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Zengli</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hannink</surname><given-names>Mark</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stamler</surname><given-names>Jonathan S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Zhen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Duke-NUS Graduate Medical School, Singapore, Singapore</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Biochemistry, Life Science Center, University of Missouri-Columbia, Columbia, Missouri, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Zwaka</surname><given-names>Thomas</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Baylor College of Medicine, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>zhen.yan@duke.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: JS Z. Yan Z. Yu PL. Performed the experiments: Z. Yu PL MZ. Analyzed the data: Z. Yan Z. Yu MZ. Contributed reagents/materials/analysis tools: Z. Yan MH. Wrote the paper: JS Z. Yan.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>7</day><month>5</month><year>2008</year></pub-date><volume>3</volume><issue>5</issue><elocation-id>e2086</elocation-id><history><date date-type="received"><day>30</day><month>12</month><year>2007</year></date><date date-type="accepted"><day>25</day><month>3</month><year>2008</year></date></history><copyright-statement>Yu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Oxidative skeletal muscles are more resistant than glycolytic muscles to cachexia caused by chronic heart failure and other chronic diseases. The molecular mechanism for the protection associated with oxidative phenotype remains elusive. We hypothesized that differences in reactive oxygen species (ROS) and nitric oxide (NO) determine the fiber type susceptibility. Here, we show that intraperitoneal injection of endotoxin (lipopolysaccharide, LPS) in mice resulted in higher level of ROS and greater expression of muscle-specific E3 ubiqitin ligases, muscle atrophy F-box (<italic>MAFbx)/atrogin-1</italic> and muscle RING finger-1 (<italic>MuRF1</italic>), in glycolytic white vastus lateralis muscle than in oxidative soleus muscle. By contrast, NO production, inducible NO synthase (<italic>iNos</italic>) and antioxidant gene expression were greatly enhanced in oxidative, but not in glycolytic muscles, suggesting that NO mediates protection against muscle wasting. NO donors enhanced <italic>iNos</italic> and antioxidant gene expression and blocked cytokine/endotoxin-induced <italic>MAFbx/atrogin-1</italic> expression in cultured myoblasts and in skeletal muscle <italic>in vivo</italic>. Our studies reveal a novel protective mechanism in oxidative myofibers mediated by enhanced <italic>iNos</italic> and antioxidant gene expression and suggest a significant value of enhanced NO signaling as a new therapeutic strategy for cachexia.</p></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Chronic diseases are often associated with and exacerbated by loss of lean body mass known as cachexia mainly due to skeletal muscle wasting. Recent research efforts have led to the current understanding of the molecular and signaling mechanisms responsible for skeletal muscle atrophy under various pathological conditions <xref ref-type="bibr" rid="pone.0002086-Bodine1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002086-Fielitz1">&#x0005b;7&#x0005d;</xref>. In particular, enhanced expression of muscle-specific E3 ligases, <italic>MAFbx/atrogin-1</italic> and <italic>MuRF1</italic>, with function in protein ubiquitination have been shown to mediate proteosome-dependent protein degradation in muscle wasting. Therefore, expression of these genes is now served as an early marker of skeletal muscle atrophy. Skeletal muscles of different fiber type composition have different contractile and metabolic properties. Oxidative muscles (predominantly type I and/or IIa fibers) are generally rich, while glycolytic muscles (predominantly type IId/x and/or IIb fibers) are poor, in mitochondria and capillaries. Interestingly, oxidative muscles are more resistant to atrophy than glycolytic muscles <xref ref-type="bibr" rid="pone.0002086-Shah1">&#x0005b;8&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002086-Acharyya1">&#x0005b;13&#x0005d;</xref>; however, much remains unknown regarding the molecular mechanism(s) for the fiber type-specific muscle wasting. The &#x0201c;built-in&#x0201d; protection in oxidative myofibers provides an excellent experimental model to decipher the skeletal muscle wasting process and search for new drug target(s) to treat this detrimental symptom that affects the morbidity and mortality of many chronic diseases.</p><p>ROS are well recognized to have primarily deleterious effects in mammalian cells. High level, sustained increase in ROS leads to oxidative cellular injury that plays &#x0201c;cause-effect&#x0201d; roles in the pathogenesis of chronic diseases and syndromes including cachexia. The deleterious role of ROS in muscle wasting has been shown in previous studies. Firstly, increased production of ROS <xref ref-type="bibr" rid="pone.0002086-Muller1">&#x0005b;14&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002086-Fagan1">&#x0005b;17&#x0005d;</xref> and reduced antioxidant gene expression <xref ref-type="bibr" rid="pone.0002086-Linke1">&#x0005b;18&#x0005d;</xref> are associated with muscle catabolism. Secondly, exogenous ROS activate proteosome-dependent protein degradation <xref ref-type="bibr" rid="pone.0002086-Li1">&#x0005b;6&#x0005d;</xref>. Lastly, antioxidant treatment attenuates skeletal muscle atrophy <xref ref-type="bibr" rid="pone.0002086-Bianca1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Appell1">&#x0005b;20&#x0005d;</xref>. However, little is known about the fiber type differences of oxidative stress in skeletal muscle in cachexia.</p><p>The functional role of nitric oxide (NO) and related oxides of nitrogen (reactive nitrogen species, RNS) in skeletal muscle wasting is controversial and far less well understood except that it is well known that NO synthase (NOS) expression is often increased in muscle wasting disorders <xref ref-type="bibr" rid="pone.0002086-Krolick1">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Boveris1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002086-Nin1">&#x0005b;25&#x0005d;</xref>. On the one hand, NO and RNS have been shown to acutely inhibit mitochondrial respiration and muscle contractile function <xref ref-type="bibr" rid="pone.0002086-Boveris1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Nin1">&#x0005b;25&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002086-Reid1">&#x0005b;27&#x0005d;</xref>; thus a scavenger of ROS-RNS <xref ref-type="bibr" rid="pone.0002086-Escames1">&#x0005b;23&#x0005d;</xref> or NOS inhibitor <xref ref-type="bibr" rid="pone.0002086-Nin1">&#x0005b;25&#x0005d;</xref> prevents muscle dysfunction. On the other hand, iNOS expression has been shown to increase dramatically in disease-resistant oxidative muscles following pathological challenges, and iNOS inhibition increases disease susceptibility <xref ref-type="bibr" rid="pone.0002086-Krolick1">&#x0005b;11&#x0005d;</xref>. Furthermore, chronic inhibition of NOS resulted in muscle dysfunction and atrophy <xref ref-type="bibr" rid="pone.0002086-Wang1">&#x0005b;28&#x0005d;</xref>. In light of these apparently conflicting findings, the functional role of NO and its derivatives in skeletal muscle wasting remain to be determined. In particular, there has not been an attempt to define the functional relationship between ROS and NO in skeletal muscle under the catabolic condition.</p><p>We have recently obtained comprehensive physiological, morphological, biochemical and gene expression evidence in a mouse model of chronic heart failure to indicate that oxidative myofibers are more resistant than glycolytic myofibers to chronic heart failure <xref ref-type="bibr" rid="pone.0002086-Li2">&#x0005b;12&#x0005d;</xref>. Consistently, there are significant differences between these myofibers in their atrophic response to cachetic stimuli, such as LPS and TNF-&#x003b1;. To improve our understanding of the mechanism(s) underlying the protection associated with oxidative phenotype, we designed this study to focus on fiber type-specific differences in ROS and NO and to determine if NO plays a functional role of muscle atrophic process related to cachexia. We obtained evidence that oxidative muscles had greater production of NO and expression of antioxidant genes, and endure lower oxidative burden than glycolytic muscles in response to cachectic stimuli. We then tested the hypothesis that up-regulation of antioxidant genes were dependent on NO, and thereby provided the protection from cachectic stimuli. This hypothesis was confirmed both in cultured muscle cells and in intact skeletal muscle <italic>in vivo</italic>. Results from this study provide potential mechanistic insights into the relatively greater resistance to cachexia associated with oxidative phenotype in skeletal muscle.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Endotoxin induces less ROS production and muscle-specific E3 ligase expression in mouse oxidative soleus muscle than in glycolytic white vastus lateralis muscle</title><p>Oxidative myofibers are resistant to cachectic stimuli induced by chronic heart failure and inflammatory cytokines <xref ref-type="bibr" rid="pone.0002086-Li2">&#x0005b;12&#x0005d;</xref>. One possible explanation is that systemic inflammation induces less oxidative stress in oxidative than in glycolytic myofibers. To test this hypothesis, we injected mice with endotoxin and measured protein carbonylation as an index of oxidative stress. LPS injection (12 hours) did not result significant changes in carbonylated proteins in soleus muscles, but resulted in a significant (&#x0223c;50&#x00025;) increase in white vastus lateralis muscles (<xref ref-type="fig" rid="pone-0002086-g001">Fig. 1A and 1B</xref>). LPS induced greater expression of muscle-specific E3 ligase <italic>MAFbx/atrogin-1</italic><xref ref-type="bibr" rid="pone.0002086-Bodine1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Gomes1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Lecker1">&#x0005b;4&#x0005d;</xref> in white vastus lateralis muscles than in soleus muscles (<xref ref-type="fig" rid="pone-0002086-g001">Fig. 1C and 1D</xref>). LPS also significantly increased <italic>MuRF1</italic> expression in vastus lateralis muscles, but not in soleus muscles (<xref ref-type="fig" rid="pone-0002086-g001">Fig. 1C and 1E</xref>). These findings are completely consistent with our previous findings <xref ref-type="bibr" rid="pone.0002086-Li2">&#x0005b;12&#x0005d;</xref>. Thus, endotoxin challenge results in significantly less oxidative stress, hence less activation of the proteosome-dependant protein degradation, in oxidative than in glycolytic muscles. We have also observed similar changes in a mouse model of sepsis induced by S. aureas infection (unpublished results). Therefore, the fiber type-specific muscle atrophic response appears to be relevant to various cachectic conditions that can be recapitulated by endotoxin injection.</p><fig id="pone-0002086-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002086.g001</object-id><label>Figure 1</label><caption><title>Endotoxin induces less oxidative stress and proteosome-dependent protein degradation in mouse oxidative than in glycolytic muscles.</title><p>Whole muscle homogenates and total RNA from oxidative soleus muscles (SO) and glycolytic white vastus lateralis muscles (WV) 12 hours after intraperitoneal (i.p.) injection of LPS (1 mg/kg body weight) were assayed for the carbonyl groups by immunoblot analysis (A and B) and for <italic>MAFbox/atrogin-1</italic> and <italic>MuRF1</italic> mRNA expression by semi-quantitative RT-PCR (C, D and E). A) Immunoblots show total protein carbonylation (top panel) after LPS or saline injection (Con) with &#x003b1;-tubulin (bottom panel) as loading reference. Each lane was loaded with 20 &#x000b5;g of proteins, and data were shown in triplicates; B) Quantification and comparison of protein carbonylation (n&#x0200a;&#x0003d;&#x0200a;12; &#x0002a;&#x0002a; <italic>P</italic>&#x0003c;0.01); C) Gel images show semi-quantitative RT-PCR analysis for <italic>MAFbx/atrogin-1</italic> and <italic>MuRF1</italic> mRNA expression with <italic>18S</italic> ribosomal RNA as control; and D) and E) Quantification and comparison of <italic>MAFbx/atrogin-1</italic> and <italic>MuRF1</italic> mRNA expression. The SO muscles from saline injected mice were set as reference (n&#x0200a;&#x0003d;&#x0200a;6; &#x0002a;&#x0002a; and &#x0002a;&#x0002a;&#x0002a; <italic>P</italic>&#x0003c;0.01 and 0.001, respectively).</p></caption><graphic xlink:href="pone.0002086.g001"/></fig></sec><sec id="s2b"><title>Endotoxin induces greater NO production and iNOS expression in mouse oxidative soleus muscle than in glycolytic white vastus lateralis muscle</title><p>To understand the possible functional role of NO-dependent signaling/gene regulation in fiber type specificity of muscle wasting, we assessed NO production in both soleus and white vastus lateralis muscles by measuring the stable NO product, nitrite. Nitrite concentration was not significantly different between these two muscles under basal conditions. However, LPS injection led to &#x0223c;100&#x00025; increase in nitrite concentration in soleus muscles, but not in white vastus lateralis muscles (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2A</xref>). The increase in nitrite in soleus muscle was associated with an enhanced iNOS expression (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2B, 2C and 2F</xref>) with majority of protein confined to the periphery of oxidative myofibers. In contrast, neuronal NO synthase <italic>(nNos)</italic> expression was reduced in both soleus and white vastus lateralis muscles (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2D</xref>), whereas endothelial NO synthase <italic>(eNos)</italic> expression was low in white vastus lateralis muscles under basal conditions and was induced to a level comparable to that in the soleus muscles (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2E</xref>) following LPS injection. These findings suggest that oxidative myofibers have great inducibility in NO production, probably through induced expression of iNOS.</p><fig id="pone-0002086-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002086.g002</object-id><label>Figure 2</label><caption><title>Endotoxin induces greater iNOS expression and NO production in mouse oxidative than in glycolytic muscles.</title><p>Whole muscle homogenates, total RNA and muscle sections from SO and WV after LPS or saline injection were assayed for nitrite (A), <italic>iNos</italic>, <italic>nNos</italic> and <italic>eNos</italic> mRNA expression by semi-quantitative RT-PCR (B,C, D and E), and iNOS protein expression by immunofluorescence (F). A) Quantification and comparison of nitrite concentration (n&#x0200a;&#x0003d;&#x0200a;5&#x02013;6; &#x0002a;&#x0002a; <italic>P</italic>&#x0003c;0.01); B) Gel images show levels of <italic>iNos</italic>, <italic>nNos</italic> and <italic>eNos</italic> mRNA expression with <italic>18S</italic> ribosomal RNA as control; C), D) and E) Quantification and comparison of <italic>iNos</italic>, <italic>nNos</italic> and <italic>eNos</italic> mRNA expression. The SO muscles from saline injected mice were set as reference (n&#x0200a;&#x0003d;&#x0200a;9; &#x0002a;&#x0002a; and &#x0002a;&#x0002a;&#x0002a; <italic>P</italic>&#x0003c;0.01 and 0.001, respectively); and F) Immunofluorescence staining for iNOS protein after LPS or saline (Con) injections (12 hours), showing higher level of basal and induced expression of iNOS in SO vs. WV muscles.</p></caption><graphic xlink:href="pone.0002086.g002"/></fig></sec><sec id="s2c"><title>Endotoxin induces greater antioxidant gene expression in oxidative soleus muscle than in glycolytic white vastus lateralis muscle</title><p>Our finding of less oxidative stress in soleus muscles than white vastus lateralis muscles following endotoxin challenge prompted us to determine if enhanced antioxidant gene expression contributes to the protection of oxidative myofibers. We performed semi-quantitative RT-PCR analysis for mRNA of the antioxidant genes: superoxide dismutases (<italic>Sod1, Sod2</italic> and <italic>Sod3</italic>) and catalase (<italic>Cat</italic>). LPS injection resulted in significantly increased expression for all four antioxidant genes in soleus muscles with no or less increases in white vastus lateralis muscles (<xref ref-type="fig" rid="pone-0002086-g003">Fig. 3A&#x02013;E</xref>). We have, therefore, obtained evidence for differentially enhanced antioxidant gene expression in oxidative vs. glycolytic myofibers that are likely intrinsic to the muscles.</p><fig id="pone-0002086-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002086.g003</object-id><label>Figure 3</label><caption><title>Endotoxin induces greater antioxidant gene expression in mouse oxidative than in glycolytic muscles.</title><p>Total RNA from SO and WV after LPS or saline (Con) injection were assayed for antioxidant gene expression by semi-quantitative RT-PCR. A) Gel images show levels of <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3 and Cat</italic> mRNA expression with <italic>18S</italic> ribosomal RNA as control; and B), C), D) and E) Quantification and comparison of <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3 and Cat</italic> mRNA, respectively (n&#x0200a;&#x0003d;&#x0200a;9; &#x0002a;, &#x0002a;&#x0002a; and &#x0002a;&#x0002a;&#x0002a; <italic>P</italic>&#x0003c;0.05, 0.01 and 0.001, respectively).</p></caption><graphic xlink:href="pone.0002086.g003"/></fig></sec><sec id="s2d"><title>NO donor blocks TNF-&#x003b1;-induced muscle-specific E3 ligase expression and enhances iNOS and antioxidant gene expression in cultured muscle cells</title><p>Our findings that there are greater increases in NO production and antioxidant gene expression in oxidative than glycolytic muscles in response to cachectic stimuli suggest a functional link between NO production and the antioxidant defense system. To test this hypothesis, we cultured mouse C2C12 myoblasts with TNF-&#x003b1; in the presence and absence of NO donor, diethylenetriamine NO (DETA-NO). DETA-NO resulted in a moderate, but significant, reduction in the basal level expression <italic>MAFbx/atrogin-1</italic> mRNA and completely blocked the induction of <italic>MAFbx/atrogin-1</italic> induced by TNF-&#x003b1; (<xref ref-type="fig" rid="pone-0002086-g004">Fig. 4A and 4B</xref>). DETA-NO enhanced TNF-&#x003b1;-induced <italic>iNos</italic> expression significantly (<xref ref-type="fig" rid="pone-0002086-g004">Fig. 4C and 4D</xref>). These findings indicate that NO is sufficient to reduce cytokine-induced activation of the proteosome-dependent catabolic pathway, which appears to be mediated by iNOS. To determine if NO induces antioxidant gene expression, we performed semi-quantitative RT-PCR analysis for <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3</italic> and <italic>Cat</italic>. DETA-NO increased the basal level and TNF-&#x003b1;-induced <italic>Sod3</italic> and <italic>Cat</italic> expression, whereas Sod1 and Sod2 were not responsive (<xref ref-type="fig" rid="pone-0002086-g004">Fig. 4E&#x02013;4I</xref>), suggesting that <italic>Sod3</italic> and <italic>Cat</italic> play an important role in mitigating oxidative stress induced by cytokines in myocytes. To further confirm that these findings are due to NO-dependent transcriptional activation of the antioxidant genes, we transfected C2C12 myoblasts with the antioxidant response element (ARE) TATA-Inr luciferase reporter gene, pARE-Luc <xref ref-type="bibr" rid="pone.0002086-Wasserman1">&#x0005b;29&#x0005d;</xref>, and treated the myoblasts with or without DETA-NO for 24 hours <xref ref-type="bibr" rid="pone.0002086-Zhang1">&#x0005b;30&#x0005d;</xref>. The reporter gene expression was significantly stimulated by NO donor, suggesting that NO stimulates antioxidant genes through the <italic>cis</italic>-acting ARE DNA sequences.</p><fig id="pone-0002086-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002086.g004</object-id><label>Figure 4</label><caption><title>NO enhances <italic>iNos</italic> and antioxidant gene expression, and blocks TNF-&#x003b1;-induced <italic>MAFbx/atrogin-1</italic> mRNA expression in cultured myoblasts.</title><p>Total RNA from cultured C2C12 myoblasts following treatment with NO donor, DETA-NO (0.2 mM), for 24 hours in the presence or absence of TNF-&#x003b1; (10 ng/ml) were assayed for <italic>MAFbx/atrogin-1</italic>, <italic>iNos</italic> and antioxidant gene expression by semi-quantitative RT-PCR and total protein lysates from transfected C2C12 myoblasts were harvested and assayed for luciferase activities. A) Gel images show levels of <italic>MAFbx/atrogin-1</italic> mRNA expression (in triplicates) with <italic>18S</italic> ribosomal RNA as control; B) Quantification and comparison of <italic>MAFbx/atrogin-1</italic> mRNA (n&#x0200a;&#x0003d;&#x0200a;11; &#x0002a;&#x0002a; and &#x0002a;&#x0002a;&#x0002a; <italic>P</italic>&#x0003c;0.01 and 0.001, respectively); C) Gel images show levels of <italic>iNos</italic> mRNA expression with <italic>18S</italic> ribosomal RNA as control; D) Quantification and comparison of <italic>iNos</italic> mRNA (n&#x0200a;&#x0003d;&#x0200a;6; &#x0002a;&#x0002a; P&#x0003c;0.01); E) Gel images show levels of <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3 and Cat</italic> mRNA expression with <italic>18S</italic> ribosomal RNA as control; F), G), H) and I) Quantification and comparison of <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3 and Cat</italic> mRNA, respectively (n&#x0200a;&#x0003d;&#x0200a;6; &#x0002a; and &#x0002a;&#x0002a; P&#x0003c;0.05 and 0.01, respectively); and J) pARE-Luc reporter gene activity in C2C12 myoblasts treated with or without DETA-NO for 24 hours (n&#x0200a;&#x0003d;&#x0200a;6; &#x0002a; P&#x0003c;0.05).</p></caption><graphic xlink:href="pone.0002086.g004"/></fig></sec><sec id="s2e"><title>S-nitrosoglutathione (GSNO) blocks endotoxin-induced muscle-specific E3 ligase expression and enhances iNOS and antioxidant gene expression in skeletal muscle <italic>in vivo</italic></title><p>The findings in cultured muscle cells motivated an <italic>in vivo</italic> study to confirm the functional role of NO in intact skeletal muscle. We injected the mice with the endogenous NO donor, GSNO (1 mg/kg, i.p.; 6 hours before and immediately before LPS injection) and performed semi-quantitative RT-PCR analysis in plantaris muscles (a muscle with a mixture of both oxidative type IIa and glycolytic type IId/x and IIb fibers). GSNO effectively blocked <italic>MAFbx/atrogin-1</italic> mRNA expression induced by LPS (<xref ref-type="fig" rid="pone-0002086-g005">Fig. 5A and 5B</xref>) and promoted <italic>iNos</italic> mRNA expression both with and without LPS injection (<xref ref-type="fig" rid="pone-0002086-g005">Fig. 5C and 5D</xref>). Therefore, NO protects myofibers from endotoxin-induced oxidative stress and prevent activation of the proteosome-dependent catabolic pathway, possibly through induced expression of iNOS. RT-PCR analysis for <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3</italic> and <italic>Cat</italic> in plantaris muscles showed that GSNO resulted in increases in <italic>Sod3</italic> and <italic>Cat</italic>, but not <italic>Sod1</italic> and <italic>Sod2</italic>, expression with and without LPS injection (<xref ref-type="fig" rid="pone-0002086-g005">Fig. 5E&#x02013;5I</xref>). These findings were entirely consistent with the findings in cultured myoblasts, suggesting the importance of SOD3 and CAT in NO-mediated protection against cachetic stimuli.</p><fig id="pone-0002086-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002086.g005</object-id><label>Figure 5</label><caption><title>GSNO enhances <italic>iNos</italic> and antioxidant gene expression, and blocks LPS-induced <italic>MAFbx/atrogin-1</italic> mRNA expression in mouse plantaris muscles.</title><p>Total RNA following NO donor GSNO injections (1 mg/kg, i.p. twice) in mice with LPS (1 mg/kg) or saline injection (Con) were assayed for <italic>MAFbx/atrogin-1</italic>, <italic>iNos</italic> and antioxidant enzyme mRNA expression by semi-quantitative RT-PCR. A) Gel images show levels of <italic>MAFbx/atrogin-1</italic> mRNA expression (in triplicates) with <italic>18S</italic> ribosomal RNA as control; B) Quantification and comparison of <italic>MAFbx/atrogin-1</italic> mRNA (n&#x0200a;&#x0003d;&#x0200a;11; &#x0002a;&#x0002a; and &#x0002a;&#x0002a;&#x0002a;<italic>P</italic>&#x0003c;0.01 and 0.001, respectively); C) Gel images show levels of <italic>iNos</italic> mRNA expression with <italic>18S</italic> ribosomal RNA as control; D) Quantification and comparison of <italic>iNos</italic> mRNA (n&#x0200a;&#x0003d;&#x0200a;6; &#x0002a;&#x0002a; and &#x0002a;&#x0002a;&#x0002a; P&#x0003c;0.01 and 0.001, respectively); E) Gel images show levels of <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3 and Cat</italic> mRNA expression with <italic>18S</italic> ribosomal RNA as control; and F), G), H) and I) Quantification and comparison of <italic>Sod1</italic>, <italic>Sod2</italic>, <italic>Sod3 and Cat</italic> mRNA, respectively (n&#x0200a;&#x0003d;&#x0200a;6; &#x0002a; and &#x0002a;&#x0002a; P&#x0003c;0.05, and 0.01, respectively).</p></caption><graphic xlink:href="pone.0002086.g005"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>The mechanisms underlying the protection of oxidative myofibers against cachexia have been unclear. The major findings of this study are: 1) Protein oxidation and degradative protein (muscle-specific E3 ubiquitin ligase) expression were lower in oxidative than in glycolytic muscles in response to cachectic stimuli; 2) iNOS expression, NO production and antioxidant gene expression were higher in oxidative muscles than in glycolytic muscles; and 3) NO donors enhanced iNOS and antioxidant gene expression and attenuated atrophic muscle responses both <italic>in vitro</italic> and <italic>in vivo</italic>. These findings together strongly suggest that NO-dependent up-regulation of the antioxidant genes, at least partly mediated by iNOS, protects oxidative myofibers against cachectic stimuli. The studies not only provide potential mechanistic insights into the functional protection in oxidative muscle fibers, but also suggest the therapeutic value of enhanced NO signaling to the treatment of muscle wasting.</p><p>The fiber type-specific muscle wasting could be due to an intrinsic difference(s) in the oxidant/antioxidant system. We have recently shown that oxidative myofibers are protected from cachectic stimuli, such as LPS and TNF-&#x003b1; <xref ref-type="bibr" rid="pone.0002086-Li2">&#x0005b;12&#x0005d;</xref>. The finding in this study that endotoxin resulted in significantly less protein oxidation in oxidative muscle than in glycolytic muscle (<xref ref-type="fig" rid="pone-0002086-g001">Fig. 1A and 1B</xref>) is consistent with the notion that a more robust basal and/or inducible antioxidant system in oxidative myofibers prevents ROS from accumulating to a high level causing cellular damage. In fact, it has been shown that oxidative muscles have more robust expression and activity of antioxidant enzymes than glycolytic muscles <xref ref-type="bibr" rid="pone.0002086-Hollander1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Ji1">&#x0005b;32&#x0005d;</xref>, and there is less mitochondrial superoxide production in oxidative myofibers than glycolytic myofibers <xref ref-type="bibr" rid="pone.0002086-Anderson1">&#x0005b;33&#x0005d;</xref>. Our findings of enhanced antioxidant gene expression in oxidative muscles (<xref ref-type="fig" rid="pone-0002086-g003">Fig. 3A&#x02013;3E</xref>) suggest that an inducible antioxidant system provides additional protection against muscle catabolism. Elucidation of the mechanism responsible for such an inducible defense system will likely lead to the discovery of new drug target(s) for cachexia.</p><p>We also found that oxidative muscles produce more NO than glycolytic muscle and exhibit attenuated atrophic responses following endotoxin challenge (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2A</xref>), raising the possibility of a cause-effect relationship between NO and muscle protection. Paradoxically, it has been shown that NO and RNS inhibit mitochondrial respiration and muscle contractile function <xref ref-type="bibr" rid="pone.0002086-Boveris1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Nin1">&#x0005b;25&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002086-Reid1">&#x0005b;27&#x0005d;</xref>, which could be prevented by ROS-RNS scavengers <xref ref-type="bibr" rid="pone.0002086-Escames1">&#x0005b;23&#x0005d;</xref> or NOS inhibitors <xref ref-type="bibr" rid="pone.0002086-Nin1">&#x0005b;25&#x0005d;</xref>. The interpretation was that iNOS mediated NO production was detrimental to muscle wasting. These previous findings were obtained in <italic>ex vivo</italic> experiments focusing on the acute effect of NO on muscle metabolic and contractile functions. Therefore, the mechanism(s) by which NO may protect against long-term muscle injury is currently not known. Our fiber type-specific analysis provides exciting new insight, suggesting induced NO production may play a protection against cachectic stimuli, rather than mediate muscle wasting.</p><p>NO production in skeletal muscle could involve nNOS (NOS1), iNOS (NOS2) and/or eNOS (NOS3) as they have been detected in skeletal muscles. A recent study showed that LPS injection resulted in increased NO production and changes in redox state in skeletal muscle, which were absent in <italic>iNos</italic><sup>&#x02212;/&#x02212;</sup> mice <xref ref-type="bibr" rid="pone.0002086-Escames1">&#x0005b;23&#x0005d;</xref>, demonstrating the relevance of iNOS in muscle wasting. Here, we observed that induced iNOS expression was associated with increased NO production in oxidative muscle that was protected from endotoxin challenge (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2A, 2B, 2C and 2F</xref>). In contrast, endotoxin resulted in decreased <italic>nNos</italic> expression in both oxidative and glycolytic muscles (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2B and 2D</xref>). nNOS protein is specifically expressed in glycolytic myofibers as part of dystrophin glycoprotein complex <xref ref-type="bibr" rid="pone.0002086-Grozdanovic1">&#x0005b;34&#x0005d;</xref> that maintains skeletal muscle contractile function <xref ref-type="bibr" rid="pone.0002086-Chang1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Comtois1">&#x0005b;36&#x0005d;</xref>; reduced <italic>nNos</italic> expression here is consistent with a general sarcolemmal injury <xref ref-type="bibr" rid="pone.0002086-Comtois1">&#x0005b;36&#x0005d;</xref>. On the other hand, induced <italic>eNos</italic> expression in glycolytic myofibers (<xref ref-type="fig" rid="pone-0002086-g002">Fig. 2B and 2E</xref>) does not reconcile with the protection in oxidative myofibers. Taken together, cachexia-induced NO production in skeletal muscle appears to be mediated through enhanced iNOS expression. The apparent feed-forward regulation of NO production may prove to be critical in amplifying the signals necessary for the protection associated with oxidative phenotype.</p><p>Paradoxically, melatonin, a powerful scavenger of both ROS and RNS, abolished the increases in NO production and GSSG/GSH ratio in isolated mitochondria from skeletal muscles <xref ref-type="bibr" rid="pone.0002086-Escames1">&#x0005b;23&#x0005d;</xref> and heart <xref ref-type="bibr" rid="pone.0002086-Escames2">&#x0005b;37&#x0005d;</xref> in mice challenged with endotoxin; these increases were absent in <italic>iNos<sup>&#x02212;/&#x02212;</sup></italic> mice. Our confined staining of oxidative myofibers of iNOS to the periphery is most consistent with mitochondrial localization of iNOS protein, which is in agreement with a recent finding <xref ref-type="bibr" rid="pone.0002086-Escames1">&#x0005b;23&#x0005d;</xref>. The previous findings that cachetic responses were absent in <italic>iNos<sup>&#x02212;/&#x02212;</sup></italic> mice were interpreted as evidence that iNOS was responsible for mitochondrial dysfunction and oxidative stress in muscles wasting. However, precaution should be taken regarding these findings with overall inhibition of iNOS since whole body genetic disruption of the <italic>iNos</italic> gene and application of iNOS inhibitor leads to loss of iNOS function not only in skeletal muscles, but also in macrophages, which is critical for the induction of sepsis <xref ref-type="bibr" rid="pone.0002086-Lowenstein1">&#x0005b;38&#x0005d;</xref>. On the other hand, a powerful protective function of iNOS in skeletal muscle are suggested in previous studies using a rat model of myasthenia gravis <xref ref-type="bibr" rid="pone.0002086-Krolick1">&#x0005b;11&#x0005d;</xref> caused by autoantibodies binding to and inhibiting the nicotinic acetylcholine receptors at the neuromuscular junctions. iNOS inhibitor converted disease-resistant soleus muscle to a disease-susceptible phenotype <xref ref-type="bibr" rid="pone.0002086-Krolick1">&#x0005b;11&#x0005d;</xref>. In this study, both <italic>in vitro</italic> and <italic>in vivo</italic> findings provide strong evidence support the protective function of NO in skeletal muscle in cachexia. Nevertheless, a formal confirmation of iNOS function in skeletal muscle awaits the generation of an animal model of skeletal muscle-specific knockout of the <italic>iNos</italic> gene.</p><p>We observed significant enhanced antioxidant genes in oxidative soleus muscles, but not in glycolytic white vastus lateralis muscles (<xref ref-type="fig" rid="pone-0002086-g003">Fig. 3A&#x02013;3E</xref>), a first demonstration of fiber type-specific induction of antioxidant genes in a whole animal model of muscle wasting. We then addressed the question whether enhanced NO production/signaling renders protection against cachetic stimuli induced by endotoxin/cytokine. Both <italic>in vitro</italic> and <italic>in vivo</italic> findings suggest that NO reduces atrophic responses and enhances antioxidant gene expression in skeletal muscles (<xref ref-type="fig" rid="pone-0002086-g004">Fig. 4</xref> and <xref ref-type="fig" rid="pone-0002086-g005">5</xref>). To our knowledge, this is the first demonstration of simultaneous, fiber type-specific induction of <italic>Sod3</italic> and <italic>Cat</italic>. Based on these findings, we now conclude that oxidative myofibers possess an intact NO-dependent signaling and transcription system protecting the myofibers from oxidative stress by enhancing the antioxidant system. The finding of enhanced reporter gene activity in cultured muscle cells transfected with the ARE reporter gene (<xref ref-type="fig" rid="pone-0002086-g004">Fig. 4J</xref>) further supports this conclusion and provides more direct evidence of transcriptional control. Further research should focus on the link between the NO signal and the transcriptional factors in skeletal muscle that is responsible for the inducible defense system.</p><p>It is worth noticing that NO donor was sufficient both in vitro and in vivo to induce iNOS expression (<xref ref-type="fig" rid="pone-0002086-g004">Fig. 4C and 4D</xref> and <xref ref-type="fig" rid="pone-0002086-g005">Fig. 5C and 5D</xref>), suggesting that both culture muscle cells and skeletal muscles have intact machineries to induce iNOS expression; the difference may be that oxidative muscle, but not glycolytic muscle, has the ability to trigger the initial increase in NO production. Future experiments should focus on elucidating the mechanism underlying this important regulatory event.</p><p>Accumulating evidence supports the view that NO and RNS play protective functions in various tissues/organs and disease models <xref ref-type="bibr" rid="pone.0002086-Kawano1">&#x0005b;39&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002086-Davila1">&#x0005b;41&#x0005d;</xref>. Perhaps, the most relevant findings are in the heart <xref ref-type="bibr" rid="pone.0002086-Ockaili1">&#x0005b;42&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002086-Das1">&#x0005b;43&#x0005d;</xref> through an iNOS-dependent mechanism <xref ref-type="bibr" rid="pone.0002086-Salloum1">&#x0005b;44&#x0005d;</xref> as cardiac muscle has metabolic and contractile functions that more closely resemble oxidative skeletal muscles. More recently, a calcineurin/NFAT (nuclear factor of activated T-cells) signaling cascade has been implicated in cardiomyocyte protection through the transcriptional control of the <italic>iNos</italic> gene <xref ref-type="bibr" rid="pone.0002086-ObasanjoBlackshire1">&#x0005b;45&#x0005d;</xref>. Ours is the first report that NO and RNS play a protective role against cachetic stimuli in skeletal muscle. We believe that NO elicits signaling events leading to the transcriptional activation of the antioxidant genes though the exact signaling and molecular mechanisms responsible for the up-regulation of the antioxidant genes remain to be elucidated.</p><p>In summary, findings from this study are consistent with a hypothesis as following. Cachexia leads to increased oxidative stress and consequently activation of protein degradation pathways in glycolytic myofibers. Enhanced iNOS expression and NO production lead to enhanced antioxidant gene expression in oxidative myofibers, providing protection against oxidative stress (<xref ref-type="fig" rid="pone-0002086-g006">Fig. 6</xref>). These findings suggest a therapeutic value of enhancing NO signaling in skeletal muscle for cachexia. Future investigations should ascertain the functional role of enhanced NO signaling in protection against various types of muscle atrophy and elucidate the molecular mechanism(s) responsible for the fiber type-specific expression of <italic>iNos</italic> and antioxidant genes. It should be noted that skeletal muscle wasting during cachexia could be affected by protein synthesis, protein degradation, autophagy and other processes. The finding of linking NO-dependent inducible antioxidant system to reduced atrogene expression may represent one of the mechanisms of endogenous defense systems in skeletal muscle under the condition of cachectic challenges.</p><fig id="pone-0002086-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002086.g006</object-id><label>Figure 6</label><caption><title>Schematic presentation of a novel framework for oxidative phenotype-associated protection against muscle wasting.</title><p>Cachectic factors increase ROS in glycolytic myofibers; oxidative stress in turn results in up-regulation of atrophic genes (atrogenes), enhances protein degradation and muscle atrophy. ROS are reduced in oxidative myofibers due to expression of iNOS and NO-dependent up-regulation of the antioxidant genes, leading to less atrogene expression and protein degradation. Thick and thin arrows represent great and little increase/stimulation, respectively.</p></caption><graphic xlink:href="pone.0002086.g006"/></fig></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Experimental animals</title><p>Male C57BL/6 mice (8&#x02013;9 weeks old) from the Jackson Laboratory (Bar Harbor, ME) were maintained in light- (12&#x02236;12 h light-dark cycle) and temperature-controlled quarter (21&#x000b0;C) provided with water and chow (Purina, Richmond, IN) <italic>ad libitum</italic>. They were intraperitoneally injected (i.p. 1 mg/kg) with <italic>E. coli</italic> LPS (Sigma, St. Louis, MO) or normal saline 12 hours before being sacrificed by isoflurane-induced anesthesia and cervical dislocation. LPS injection did not result in morbidity or mortality. Soleus and white vastus lateralis muscles were harvested. To determine the role of NO donor <italic>in vivo</italic>, GSNO (Sigma, St. Louis, MO) were injected (i.p. 1 mg/kg) twice (6 hours prior to and at the time of LPS or normal saline injection). Plantaris muscles were harvested 12 hours later. All animal protocols were approved by the Duke University Institutional Animal Care and Use Committee.</p></sec><sec id="s4b"><title>Protein carbonylation assay</title><p>To determine the level of oxidative stress in skeletal muscle, carbonyl levels of proteins were determined in whole muscle lysates by using the OxyBlot&#x02122; Protein Oxidation Detection Kit (Serologicals Corporation, Norcross, GA). Briefly, harvested skeletal muscles were placed in 5-ml Falcon tubes each containing 1 ml of ice-cold Protein Lysis Buffer (Cell Signaling Technology, Danvers, MA) supplemented with 50 mM dithiothreitol (DDT) and 1 mM phenylmethylsulphonyl fluoride (PMSF) and homogenized with an Ultra Turrax T25 Polytron&#x02122; homogenizer. The homogenates were centrifuged at 16,000 &#x000d7; g for 5 min at 4&#x000b0;C, and the supernatants were then transferred to 10K NMMWL-0.5 ml Ultrafree Filter Unit (Millipore, Bedford, MA) and centrifuged at 16,000 &#x000d7; g at 4&#x000b0;C (about 30 min) to concentrate to a volume of about 60 &#x000b5;l. Protein concentration was then determined by using the RC DC protein assay (BioRad, Hercules, CA). Protein carbonylation was then determined in the whole muscle lysate (20 &#x000b5;g protein) by an immunblot-based assay according to the instructions from the manufacturer. The intensities of all the bands in each of the lanes were quantified by using Scion Image (Scion Corporation, Frederick, Maryland) and normalized by &#x003b1;-tubulin.</p></sec><sec id="s4c"><title>Nitrite assay</title><p>Nitrite was assessed using the Griess Reagent System (Promega, Madison, WI). In brief, harvested skeletal muscles were homogenized immediately in ice-cold Protein Lysis Buffer (Cell Signaling Technology, Danvers, MA) containing 1 mM PMSF in a Wheaton glass-on-glass homogenizer on ice, and the homogenate was centrifuged at 16,000 &#x000d7; g for 5 min at 4&#x000b0;C. The protein concentration of the supernatants was determined as described above. The nitrite assay was started by adding the sample (360 &#x000b5;g proteins in 50 &#x000b5;l) to 50 &#x000b5;l sulfanilamide solutions in 96-well plates in duplicate. After incubation at room temperature for 10 min, 50 &#x000b5;l of the N-1-napthylethylenediamine dihydrochloride (NED) solution was added, and the reaction was continued for another 10 min. Absorbance at 550 nm was then measured, and nitrite concentration was calculated after normalization by total protein.</p></sec><sec id="s4d"><title>Cell culture</title><p>C2C12 mouse myoblasts were grown and maintained as sub-confluent monolayer in high-glucose Dulbecco modified Eagle medium (DMEM; Gibco BRL, Grand Island, NY) supplemented with 20&#x00025; fetal bovine serum (FBS, Gibco BRL, Grand Island, NY). To examine the effect of NO donor and iNOS inhibitor, C2C12 cells seeded in 35 mm-wells at 1 &#x000d7; 10<sup>5</sup> and allowed to adhere for at least 12 hour prior to stimulation by TNF-&#x003b1; (R&#x00026;D Systems, Minneapolis, MN) at 10 ng/ml with/without DETA-NO (Sigma, St. Louis, MO). The cells were harvested 20 hours later, and total RNA samples were isolated for RT-PCR analysis by using Trizol (Invitrogen, Carlsbad, CA). For transfection of pARE-Luc, C2C12 myoblasts were transfected with 0.5 &#x000b5;g with Lipofectamine 2000 according the manufacturer's instructions. After overnight transfection, the transfected cells were treated with/without DETA-NO (10 ng/ml) for 24 hours. Luciferase activity was assayed and is expressed as relative activity (fold change) in comparison to the value of transfected cells without DETA-NO. The transfection was done twice with triplicate samples for each condition.</p></sec><sec id="s4e"><title>Semi-quantitative RT-PCR</title><p>This analysis was performed as described <xref ref-type="bibr" rid="pone.0002086-Li2">&#x0005b;12&#x0005d;</xref> to measure <italic>MAFbx/atrogin-1</italic>, <italic>MuRF1</italic>, <italic>iNos</italic>, superoxide dismutases (<italic>Sod-1</italic>, <italic>Sod-2</italic>, <italic>Sod-3</italic>) and catalase <italic>(Cat)</italic> mRNA expression in skeletal muscles and in cultured C2C12 myoblasts. PCR primer pairs were designed using Primer3 search engine at <ext-link ext-link-type="uri" xlink:href="http://www-genome.wi.mit.edu">www-genome.wi.mit.edu</ext-link>. The oligonuleotide primer pairs used in this study corresponded to the following nucleotides: <italic>MAFbx/atrogin-1</italic>: 1917&#x02013;1936 and 2415&#x02013;2396 (NM_026346); <italic>MuRF1</italic>: 50&#x02013;69 and 452&#x02013;433 (AF294790); <italic>iNos</italic>: 1815&#x02013;1834 and 2301&#x02013;2282 (MMU43428); <italic>eNOS:</italic> 1515&#x02013;1534 and 2002&#x02013;1983 (NM_008713); <italic>nNOS:</italic> 1261&#x02013;1272 and 1735&#x02013;1716 (NM_008712); <italic>Sod1:</italic> 168&#x02013;187 and 583&#x02013;564 (NM_011434); <italic>Sod2</italic>: 1218&#x02013;1237 and 1647&#x02013;1628 (BC066063); <italic>Sod3</italic>: 1547&#x02013;1566 and 2019&#x02013;2000 (NM_011435); and <italic>Cat</italic>: 237&#x02013;256 and 645&#x02013;626 (MMU43428). Results were normalized by <italic>18S</italic> rRNA and presented as fold change to soleus muscle in mice injected with normal saline.</p></sec><sec id="s4f"><title>Statistics</title><p>Data are presented as mean&#x000b1;standard error. For comparisons involving two factors, two-way ANOVA was performed followed by the Newman-Kuels test. For comparisons between two groups, the Student t-test was performed. <italic>P</italic>&#x0003c;0.05 was accepted as statistically significant for all the experiments in this study.</p></sec></sec></body><back><ack><p>We greatly appreciate Ms. Beverley Fermor for the excellent technical assistance in the nitrite assay.</p></ack><ref-list><title>References</title><ref id="pone.0002086-Bodine1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodine</surname><given-names>SC</given-names></name><name><surname>Latres</surname><given-names>E</given-names></name><name><surname>Baumhueter</surname><given-names>S</given-names></name><name><surname>Lai</surname><given-names>VK</given-names></name><name><surname>Nunez</surname><given-names>L</given-names></name><etal/></person-group><year>2001</year><article-title>Identification of ubiquitin ligases required for skeletal muscle atrophy.</article-title><source>Science</source><volume>294</volume><fpage>1704</fpage><lpage>1708</lpage><pub-id pub-id-type="pmid">11679633</pub-id></citation></ref><ref id="pone.0002086-Cai1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>D</given-names></name><name><surname>Frantz</surname><given-names>JD</given-names></name><name><surname>Tawa</surname><given-names>NE</given-names><suffix>Jr</suffix></name><name><surname>Melendez</surname><given-names>PA</given-names></name><name><surname>Oh</surname><given-names>BC</given-names></name><etal/></person-group><year>2004</year><article-title>IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.</article-title><source>Cell</source><volume>119</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">15479644</pub-id></citation></ref><ref id="pone.0002086-Gomes1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>MD</given-names></name><name><surname>Lecker</surname><given-names>SH</given-names></name><name><surname>Jagoe</surname><given-names>RT</given-names></name><name><surname>Navon</surname><given-names>A</given-names></name><name><surname>Goldberg</surname><given-names>AL</given-names></name></person-group><year>2001</year><article-title>Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>14440</fpage><lpage>14445</lpage><pub-id pub-id-type="pmid">11717410</pub-id></citation></ref><ref id="pone.0002086-Lecker1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lecker</surname><given-names>SH</given-names></name><name><surname>Jagoe</surname><given-names>RT</given-names></name><name><surname>Gilbert</surname><given-names>A</given-names></name><name><surname>Gomes</surname><given-names>M</given-names></name><name><surname>Baracos</surname><given-names>V</given-names></name><etal/></person-group><year>2004</year><article-title>Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.</article-title><source>Faseb J</source><volume>18</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">14718385</pub-id></citation></ref><ref id="pone.0002086-Sandri1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandri</surname><given-names>M</given-names></name><name><surname>Sandri</surname><given-names>C</given-names></name><name><surname>Gilbert</surname><given-names>A</given-names></name><name><surname>Skurk</surname><given-names>C</given-names></name><name><surname>Calabria</surname><given-names>E</given-names></name><etal/></person-group><year>2004</year><article-title>Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.</article-title><source>Cell</source><volume>117</volume><fpage>399</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">15109499</pub-id></citation></ref><ref id="pone.0002086-Li1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YP</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>AS</given-names></name><name><surname>Reid</surname><given-names>MB</given-names></name></person-group><year>2003</year><article-title>Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes.</article-title><source>Am J Physiol Cell Physiol</source><volume>285</volume><fpage>C806</fpage><lpage>812</lpage><pub-id pub-id-type="pmid">12773310</pub-id></citation></ref><ref id="pone.0002086-Fielitz1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fielitz</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Shelton</surname><given-names>JM</given-names></name><name><surname>Latif</surname><given-names>S</given-names></name><name><surname>Spencer</surname><given-names>JA</given-names></name><etal/></person-group><year>2007</year><article-title>Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.</article-title><source>J Clin Invest</source><volume>117</volume><fpage>2486</fpage><lpage>2495</lpage><pub-id pub-id-type="pmid">17786241</pub-id></citation></ref><ref id="pone.0002086-Shah1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>AJ</given-names></name><name><surname>Sahgal</surname><given-names>V</given-names></name><name><surname>Quintanilla</surname><given-names>AP</given-names></name><name><surname>Subramani</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><etal/></person-group><year>1983</year><article-title>Muscle in chronic uremia&#x02013;a histochemical and morphometric study of human quadriceps muscle biopsies.</article-title><source>Clin Neuropathol</source><volume>2</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">6851301</pub-id></citation></ref><ref id="pone.0002086-Butori1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butori</surname><given-names>C</given-names></name><name><surname>Desnuelle</surname><given-names>C</given-names></name><name><surname>Hofman</surname><given-names>P</given-names></name><name><surname>Paquis</surname><given-names>V</given-names></name><name><surname>Durant</surname><given-names>J</given-names></name><etal/></person-group><year>1995</year><article-title>&#x0005b;Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases&#x0005d;.</article-title><source>Ann Pathol</source><volume>15</volume><fpage>424</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">8720838</pub-id></citation></ref><ref id="pone.0002086-Minnaard1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minnaard</surname><given-names>R</given-names></name><name><surname>Drost</surname><given-names>MR</given-names></name><name><surname>Wagenmakers</surname><given-names>AJ</given-names></name><name><surname>van Kranenburg</surname><given-names>GP</given-names></name><name><surname>Kuipers</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>Skeletal Muscle wasting and contractile performance in septic rats.</article-title><source>Muscle Nerve</source><volume>31</volume><fpage>339</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">15751123</pub-id></citation></ref><ref id="pone.0002086-Krolick1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krolick</surname><given-names>KA</given-names></name></person-group><year>2006</year><article-title>Muscle-derived nitric oxide synthase expression, differences associated with muscle fiber-type, and disease susceptibility in a rat model of myasthenia gravis.</article-title><source>Clin Immunol</source><volume>121</volume><fpage>286</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">16938490</pub-id></citation></ref><ref id="pone.0002086-Li2"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Waters</surname><given-names>RE</given-names></name><name><surname>Redfern</surname><given-names>SI</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Mao</surname><given-names>L</given-names></name><etal/></person-group><year>2007</year><article-title>Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice.</article-title><source>Am J Pathol</source><volume>170</volume><fpage>599</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">17255328</pub-id></citation></ref><ref id="pone.0002086-Acharyya1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acharyya</surname><given-names>S</given-names></name><name><surname>Butchbach</surname><given-names>ME</given-names></name><name><surname>Sahenk</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Saji</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.</article-title><source>Cancer Cell</source><volume>8</volume><fpage>421</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">16286249</pub-id></citation></ref><ref id="pone.0002086-Muller1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>FL</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Jang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sabia</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>Denervation-Induced Skeletal Muscle Atrophy is Associated with Increased Mitochondrial ROS Production.</article-title><source>Am J Physiol Regul Integr Comp Physiol</source></citation></ref><ref id="pone.0002086-Barreiro1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barreiro</surname><given-names>E</given-names></name><name><surname>de la Puente</surname><given-names>B</given-names></name><name><surname>Busquets</surname><given-names>S</given-names></name><name><surname>Lopez-Soriano</surname><given-names>FJ</given-names></name><name><surname>Gea</surname><given-names>J</given-names></name><etal/></person-group><year>2005</year><article-title>Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats.</article-title><source>FEBS Lett</source><volume>579</volume><fpage>1646</fpage><lpage>1652</lpage><pub-id pub-id-type="pmid">15757655</pub-id></citation></ref><ref id="pone.0002086-AriasDiaz1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arias-Diaz</surname><given-names>J</given-names></name><name><surname>Vara</surname><given-names>E</given-names></name><name><surname>Torres-Melero</surname><given-names>J</given-names></name><name><surname>Garcia</surname><given-names>C</given-names></name><name><surname>Hernandez</surname><given-names>J</given-names></name><etal/></person-group><year>1997</year><article-title>Local production of oxygen free radicals and nitric oxide in rat diaphragm during sepsis: effects of pentoxifylline and somatostatin.</article-title><source>Eur J Surg</source><volume>163</volume><fpage>619</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">9298915</pub-id></citation></ref><ref id="pone.0002086-Fagan1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fagan</surname><given-names>JM</given-names></name><name><surname>Ganguly</surname><given-names>M</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Fischer</surname><given-names>JE</given-names></name><name><surname>Hasselgren</surname><given-names>PO</given-names></name></person-group><year>1996</year><article-title>Sepsis increases oxidatively damaged proteins in skeletal muscle.</article-title><source>Arch Surg</source><volume>131</volume><fpage>1326</fpage><lpage>1331</lpage><comment>discussion 1331&#x02013;1322</comment><pub-id pub-id-type="pmid">8956775</pub-id></citation></ref><ref id="pone.0002086-Linke1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>V</given-names></name><name><surname>Schulze</surname><given-names>PC</given-names></name><name><surname>Erbs</surname><given-names>S</given-names></name><name><surname>Gielen</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle.</article-title><source>Circulation</source><volume>111</volume><fpage>1763</fpage><lpage>1770</lpage><pub-id pub-id-type="pmid">15809365</pub-id></citation></ref><ref id="pone.0002086-Bianca1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bianca</surname><given-names>RV</given-names></name><name><surname>Wayman</surname><given-names>NS</given-names></name><name><surname>McDonald</surname><given-names>MC</given-names></name><name><surname>Pinto</surname><given-names>A</given-names></name><name><surname>Shape</surname><given-names>MA</given-names></name><etal/></person-group><year>2002</year><article-title>Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat.</article-title><source>Med Sci Monit</source><volume>8</volume><fpage>BR1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11796957</pub-id></citation></ref><ref id="pone.0002086-Appell1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Appell</surname><given-names>HJ</given-names></name><name><surname>Duarte</surname><given-names>JA</given-names></name><name><surname>Soares</surname><given-names>JM</given-names></name></person-group><year>1997</year><article-title>Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy.</article-title><source>Int J Sports Med</source><volume>18</volume><fpage>157</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">9187967</pub-id></citation></ref><ref id="pone.0002086-Boveris1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boveris</surname><given-names>A</given-names></name><name><surname>Alvarez</surname><given-names>S</given-names></name><name><surname>Navarro</surname><given-names>A</given-names></name></person-group><year>2002</year><article-title>The role of mitochondrial nitric oxide synthase in inflammation and septic shock.</article-title><source>Free Radic Biol Med</source><volume>33</volume><fpage>1186</fpage><lpage>1193</lpage><pub-id pub-id-type="pmid">12398926</pub-id></citation></ref><ref id="pone.0002086-Adams1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>V</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Mobius-Winkler</surname><given-names>S</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Weigl</surname><given-names>C</given-names></name><etal/></person-group><year>1997</year><article-title>Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure.</article-title><source>Biochem Mol Med</source><volume>61</volume><fpage>152</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">9259980</pub-id></citation></ref><ref id="pone.0002086-Escames1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escames</surname><given-names>G</given-names></name><name><surname>Lopez</surname><given-names>LC</given-names></name><name><surname>Tapias</surname><given-names>V</given-names></name><name><surname>Utrilla</surname><given-names>P</given-names></name><name><surname>Reiter</surname><given-names>RJ</given-names></name><etal/></person-group><year>2006</year><article-title>Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice.</article-title><source>J Pineal Res</source><volume>40</volume><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">16313501</pub-id></citation></ref><ref id="pone.0002086-Agusti1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agusti</surname><given-names>A</given-names></name><name><surname>Morla</surname><given-names>M</given-names></name><name><surname>Sauleda</surname><given-names>J</given-names></name><name><surname>Saus</surname><given-names>C</given-names></name><name><surname>Busquets</surname><given-names>X</given-names></name></person-group><year>2004</year><article-title>NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight.</article-title><source>Thorax</source><volume>59</volume><fpage>483</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">15170030</pub-id></citation></ref><ref id="pone.0002086-Nin1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nin</surname><given-names>N</given-names></name><name><surname>Cassina</surname><given-names>A</given-names></name><name><surname>Boggia</surname><given-names>J</given-names></name><name><surname>Alfonso</surname><given-names>E</given-names></name><name><surname>Botti</surname><given-names>H</given-names></name><etal/></person-group><year>2004</year><article-title>Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition.</article-title><source>Intensive Care Med</source><volume>30</volume><fpage>2271</fpage><lpage>2278</lpage><pub-id pub-id-type="pmid">15349724</pub-id></citation></ref><ref id="pone.0002086-Abraham1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>RZ</given-names></name><name><surname>Kobzik</surname><given-names>L</given-names></name><name><surname>Moody</surname><given-names>MR</given-names></name><name><surname>Reid</surname><given-names>MB</given-names></name><name><surname>Stamler</surname><given-names>JS</given-names></name></person-group><year>1998</year><article-title>Cyclic GMP is a second messenger by which nitric oxide inhibits diaphragm contraction.</article-title><source>Comp Biochem Physiol A Mol Integr Physiol</source><volume>119</volume><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">11253783</pub-id></citation></ref><ref id="pone.0002086-Reid1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>MB</given-names></name><name><surname>Kobzik</surname><given-names>L</given-names></name><name><surname>Bredt</surname><given-names>DS</given-names></name><name><surname>Stamler</surname><given-names>JS</given-names></name></person-group><year>1998</year><article-title>Nitric oxide modulates excitation-contraction coupling in the diaphragm.</article-title><source>Comp Biochem Physiol A Mol Integr Physiol</source><volume>119</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">11253787</pub-id></citation></ref><ref id="pone.0002086-Wang1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>MX</given-names></name><name><surname>Murrell</surname><given-names>DF</given-names></name><name><surname>Szabo</surname><given-names>C</given-names></name><name><surname>Warren</surname><given-names>RF</given-names></name><name><surname>Sarris</surname><given-names>M</given-names></name><etal/></person-group><year>2001</year><article-title>Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats.</article-title><source>Nitric Oxide</source><volume>5</volume><fpage>219</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">11384195</pub-id></citation></ref><ref id="pone.0002086-Wasserman1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wasserman</surname><given-names>WW</given-names></name><name><surname>Fahl</surname><given-names>WE</given-names></name></person-group><year>1997</year><article-title>Functional antioxidant responsive elements.</article-title><source>Proc Natl Acad Sci U S A</source><volume>94</volume><fpage>5361</fpage><lpage>5366</lpage><pub-id pub-id-type="pmid">9144242</pub-id></citation></ref><ref id="pone.0002086-Zhang1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DD</given-names></name><name><surname>Lo</surname><given-names>SC</given-names></name><name><surname>Cross</surname><given-names>JV</given-names></name><name><surname>Templeton</surname><given-names>DJ</given-names></name><name><surname>Hannink</surname><given-names>M</given-names></name></person-group><year>2004</year><article-title>Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.</article-title><source>Mol Cell Biol</source><volume>24</volume><fpage>10941</fpage><lpage>10953</lpage><pub-id pub-id-type="pmid">15572695</pub-id></citation></ref><ref id="pone.0002086-Hollander1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>J</given-names></name><name><surname>Fiebig</surname><given-names>R</given-names></name><name><surname>Gore</surname><given-names>M</given-names></name><name><surname>Bejma</surname><given-names>J</given-names></name><name><surname>Ookawara</surname><given-names>T</given-names></name><etal/></person-group><year>1999</year><article-title>Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training.</article-title><source>Am J Physiol</source><volume>277</volume><fpage>R856</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">10484504</pub-id></citation></ref><ref id="pone.0002086-Ji1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>LL</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Mitchell</surname><given-names>EW</given-names></name></person-group><year>1992</year><article-title>Glutathione and antioxidant enzymes in skeletal muscle: effects of fiber type and exercise intensity.</article-title><source>J Appl Physiol</source><volume>73</volume><fpage>1854</fpage><lpage>1859</lpage><pub-id pub-id-type="pmid">1474061</pub-id></citation></ref><ref id="pone.0002086-Anderson1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>EJ</given-names></name><name><surname>Neufer</surname><given-names>PD</given-names></name></person-group><year>2006</year><article-title>Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation.</article-title><source>Am J Physiol Cell Physiol</source><volume>290</volume><fpage>C844</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">16251473</pub-id></citation></ref><ref id="pone.0002086-Grozdanovic1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grozdanovic</surname><given-names>Z</given-names></name><name><surname>Baumgarten</surname><given-names>HG</given-names></name></person-group><year>1999</year><article-title>Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex.</article-title><source>Histol Histopathol</source><volume>14</volume><fpage>243</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">9987669</pub-id></citation></ref><ref id="pone.0002086-Chang1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>WJ</given-names></name><name><surname>Iannaccone</surname><given-names>ST</given-names></name><name><surname>Lau</surname><given-names>KS</given-names></name><name><surname>Masters</surname><given-names>BS</given-names></name><name><surname>McCabe</surname><given-names>TJ</given-names></name><etal/></person-group><year>1996</year><article-title>Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>9142</fpage><lpage>9147</lpage><pub-id pub-id-type="pmid">8799168</pub-id></citation></ref><ref id="pone.0002086-Comtois1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comtois</surname><given-names>AS</given-names></name><name><surname>Barreiro</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name><name><surname>Marette</surname><given-names>A</given-names></name><name><surname>Perrault</surname><given-names>M</given-names></name><etal/></person-group><year>2001</year><article-title>Lipopolysaccharide-induced diaphragmatic contractile dysfunction and sarcolemmal injury in mice lacking the neuronal nitric oxide synthase.</article-title><source>Am J Respir Crit Care Med</source><volume>163</volume><fpage>977</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">11282776</pub-id></citation></ref><ref id="pone.0002086-Escames2"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escames</surname><given-names>G</given-names></name><name><surname>Lopez</surname><given-names>LC</given-names></name><name><surname>Ortiz</surname><given-names>F</given-names></name><name><surname>Lopez</surname><given-names>A</given-names></name><name><surname>Garcia</surname><given-names>JA</given-names></name><etal/></person-group><year>2007</year><article-title>Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice.</article-title><source>Febs J</source><volume>274</volume><fpage>2135</fpage><lpage>2147</lpage><pub-id pub-id-type="pmid">17371545</pub-id></citation></ref><ref id="pone.0002086-Lowenstein1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lowenstein</surname><given-names>CJ</given-names></name><name><surname>Glatt</surname><given-names>CS</given-names></name><name><surname>Bredt</surname><given-names>DS</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><year>1992</year><article-title>Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.</article-title><source>Proc Natl Acad Sci U S A</source><volume>89</volume><fpage>6711</fpage><lpage>6715</lpage><pub-id pub-id-type="pmid">1379716</pub-id></citation></ref><ref id="pone.0002086-Kawano1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Kunz</surname><given-names>A</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Girouard</surname><given-names>H</given-names></name><name><surname>Anrather</surname><given-names>J</given-names></name><etal/></person-group><year>2007</year><article-title>iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite.</article-title><source>J Cereb Blood Flow Metab</source></citation></ref><ref id="pone.0002086-Borniquel1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borniquel</surname><given-names>S</given-names></name><name><surname>Valle</surname><given-names>I</given-names></name><name><surname>Cadenas</surname><given-names>S</given-names></name><name><surname>Lamas</surname><given-names>S</given-names></name><name><surname>Monsalve</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha.</article-title><source>Faseb J</source><volume>20</volume><fpage>1889</fpage><lpage>1891</lpage><pub-id pub-id-type="pmid">16891621</pub-id></citation></ref><ref id="pone.0002086-Davila1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davila</surname><given-names>HH</given-names></name><name><surname>Magee</surname><given-names>TR</given-names></name><name><surname>Vernet</surname><given-names>D</given-names></name><name><surname>Rajfer</surname><given-names>J</given-names></name><name><surname>Gonzalez-Cadavid</surname><given-names>NF</given-names></name></person-group><year>2004</year><article-title>Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.</article-title><source>Biol Reprod</source><volume>71</volume><fpage>1568</fpage><lpage>1577</lpage><pub-id pub-id-type="pmid">15240426</pub-id></citation></ref><ref id="pone.0002086-Ockaili1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ockaili</surname><given-names>R</given-names></name><name><surname>Salloum</surname><given-names>F</given-names></name><name><surname>Hawkins</surname><given-names>J</given-names></name><name><surname>Kukreja</surname><given-names>RC</given-names></name></person-group><year>2002</year><article-title>Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits.</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>283</volume><fpage>H1263</fpage><lpage>1269</lpage><pub-id pub-id-type="pmid">12181158</pub-id></citation></ref><ref id="pone.0002086-Das1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Kukreja</surname><given-names>RC</given-names></name></person-group><year>2005</year><article-title>Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>12944</fpage><lpage>12955</lpage><pub-id pub-id-type="pmid">15668244</pub-id></citation></ref><ref id="pone.0002086-Salloum1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salloum</surname><given-names>F</given-names></name><name><surname>Yin</surname><given-names>C</given-names></name><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Kukreja</surname><given-names>RC</given-names></name></person-group><year>2003</year><article-title>Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.</article-title><source>Circ Res</source><volume>92</volume><fpage>595</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">12637371</pub-id></citation></ref><ref id="pone.0002086-ObasanjoBlackshire1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obasanjo-Blackshire</surname><given-names>K</given-names></name><name><surname>Mesquita</surname><given-names>R</given-names></name><name><surname>Jabr</surname><given-names>RI</given-names></name><name><surname>Molkentin</surname><given-names>JD</given-names></name><name><surname>Hart</surname><given-names>SL</given-names></name><etal/></person-group><year>2006</year><article-title>Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.</article-title><source>Cardiovasc Res</source><volume>71</volume><fpage>672</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">16828070</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This study is supported by the American Heart Association-Mid-Atlantic Affiliate Post-doctoral Fellowship 0625518 (to P.L.), National Institutes of Health R01-HLO59130 (to J.S.S), and Grant-in-Aid 0555426U (to Z.Y.).</p></fn></fn-group></back></article> 